To be effective, protein priming must induce the development of a distinct lineage of CD4+ T cells named T follicular helper (Tfh) cells, which regulate the differentiation of high-affinity memory B cells and long-lived plasma cells. In this context, we tested how adjuvantation with CpG, the Toll-like receptor 9 agonist used in clinics, contributes to antigen-specific T-cell-dependent B-cell responses in vivo. We found that addition of CpG to other vaccine adjuvant increased the differentiation of antigen-specific Tfh cells without changing the overall magnitude of the T-cell response. This phenomenon correlated with an enhancement of the germinal centre reaction, antigen-specific plasma cells and circulating antibodies. We comprehensively demonstrated that, in addition to the classical Tfh-cell differentiation mediated by conventional DC, the promoting effect due to CpG was orchestrated in vivo by antigen presentation and IL-6 secreted by monocyte-derived dendritic cells (DC) as shown in their absence. Thus, while conventional DC initiate T-cell responses, targeting monocyte-derived DC specifically enhances the Tfh programme needed to regulate high-affinity B-cell protection in vivo. © 2014 The Authors. Published under the terms of the CC BY 4.0 license.
CITATION STYLE
Chakarov, S., & Fazilleau, N. (2014). Monocyte-derived dendritic cells promote T follicular helper cell differentiation. EMBO Molecular Medicine, 6(5), 590–603. https://doi.org/10.1002/emmm.201403841
Mendeley helps you to discover research relevant for your work.